Mirati Therapeutics prices public offering, shares slide

Mirati Therapeutics (MRTX) prices its previously announced public offering at $17.50, a 3.4% discount to Wednesday's close. (8-K)

The shares fell 3.6% during Thursday's regular session.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs